Nivolumab as a second-line therapy for metastatic RCC - 100098

Spotlight
Video

Nivolumab as a second-line therapy for metastatic RCC

kidneycancer has 473 videos Subscribe Here

Loading........
Description: Saby George, MD, FACP, Associate Professor of Medicine and Oncology, Genitourinary Oncology Program , Roswell Park Cancer Institute presents
Nivolumab as a second-line therapy for metastatic RCC at the 2016 annual International Kidney Cancer Symposium.
Shared By : kidneycancer
Posted on : 11/07/16
Added : 2 years ago
Category : Kidney Cancer